Durie P - Search Results

1

Assessment of the efficacy of in vivo CFTR protein replacement therapy in CF mice.

Ramjeesingh M, Huan LJ, Wilschanski M, Durie P, Li C, Gyomorey K, Wang Y, Kent G, Tanswell KA, Cutz E, Ackerley C, Bear CE. Ramjeesingh M, et al. Among authors: durie p. Hum Gene Ther. 1998 Mar 1;9(4):521-8. doi: 10.1089/hum.1998.9.4-521. Hum Gene Ther. 1998. PMID: 9525313

2

In vivo measurements of ion transport in long-living CF mice.

Wilschanski MA, Rozmahel R, Beharry S, Kent G, Li C, Tsui LC, Durie P, Bear CE. Wilschanski MA, et al. Among authors: durie p. Biochem Biophys Res Commun. 1996 Feb 27;219(3):753-9. doi: 10.1006/bbrc.1996.0306. Biochem Biophys Res Commun. 1996. PMID: 8645253

3

Incomplete rescue of cystic fibrosis transmembrane conductance regulator deficient mice by the human CFTR cDNA.

Rozmahel R, Gyömörey K, Plyte S, Nguyen V, Wilschanski M, Durie P, Bear CE, Tsui LC. Rozmahel R, et al. Among authors: durie p. Hum Mol Genet. 1997 Jul;6(7):1153-62. doi: 10.1093/hmg/6.7.1153. Hum Mol Genet. 1997. PMID: 9215687

4

Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model.

Durie PR, Kent G, Phillips MJ, Ackerley CA. Durie PR, et al. Am J Pathol. 2004 Apr;164(4):1481-93. doi: 10.1016/S0002-9440(10)63234-8. Am J Pathol. 2004. PMID: 15039235 Free PMC article.

5

Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations.

Wilschanski M, Zielenski J, Markiewicz D, Tsui LC, Corey M, Levison H, Durie PR. Wilschanski M, et al. Among authors: durie pr. J Pediatr. 1995 Nov;127(5):705-10. doi: 10.1016/s0022-3476(95)70157-5. J Pediatr. 1995. PMID: 7472820

6

Synergistic effects of cAMP- and calcium-mediated amylase secretion in isolated pancreatic acini from cystic fibrosis mice.

Tang S, Beharry S, Kent G, Durie PR. Tang S, et al. Among authors: durie pr. Pediatr Res. 1999 Apr;45(4 Pt 1):482-8. doi: 10.1203/00006450-199904010-00005. Pediatr Res. 1999. PMID: 10203138

7

Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor.

Rozmahel R, Wilschanski M, Matin A, Plyte S, Oliver M, Auerbach W, Moore A, Forstner J, Durie P, Nadeau J, Bear C, Tsui LC. Rozmahel R, et al. Among authors: durie p. Nat Genet. 1996 Mar;12(3):280-7. doi: 10.1038/ng0396-280. Nat Genet. 1996. PMID: 8589719

8

Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials.

Wilschanski M, Dupuis A, Ellis L, Jarvi K, Zielenski J, Tullis E, Martin S, Corey M, Tsui LC, Durie P. Wilschanski M, et al. Among authors: durie p. Am J Respir Crit Care Med. 2006 Oct 1;174(7):787-94. doi: 10.1164/rccm.200509-1377OC. Epub 2006 Jul 13. Am J Respir Crit Care Med. 2006. PMID: 16840743 Free PMC article.

9

Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis.

Beharry S, Ackerley C, Corey M, Kent G, Heng YM, Christensen H, Luk C, Yantiss RK, Nasser IA, Zaman M, Freedman SD, Durie PR. Beharry S, et al. Am J Physiol Gastrointest Liver Physiol. 2007 Mar;292(3):G839-48. doi: 10.1152/ajpgi.00582.2005. Epub 2006 Nov 9. Am J Physiol Gastrointest Liver Physiol. 2007. PMID: 17095751 Free article.

10

Exocrine pancreatic alterations in long-lived surviving cystic fibrosis mice.

Ip WF, Bronsveld I, Kent G, Corey M, Durie PR. Ip WF, et al. Among authors: durie pr. Pediatr Res. 1996 Aug;40(2):242-9. doi: 10.1203/00006450-199608000-00009. Pediatr Res. 1996. PMID: 8827772

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters